Dr Reddys Laboratories (RDY) Asset Utilization Ratio (2009 - 2026)
Dr Reddys Laboratories' (RDY) Asset Utilization Ratio stood at 0.59 in fiscal Q2 2027 (quarter ended Sep 30, 2026), down 9.5% from 0.65 a year earlier and down 1.5% from the prior quarter.
Powered by 
Analysis
Dr Reddys Laboratories (RDY) Asset Utilization Ratio (2009 - 2026) Analysis & Trends
For FY2026 (ended Mar 31, 2026), Dr Reddys Laboratories' Asset Utilization Ratio came in at 0.60, down 18.1% from FY2025.
- Across earlier fiscal years, Asset Utilization Ratio came in at 0.73 in FY2025 (-6.5%), 0.78 in FY2024 (+1.6%), 0.77 in FY2023 (+2.0%) and 0.75 in FY2022 (-2.4%).
- The fiscal Q2 2027 figure is the lowest quarterly Asset Utilization Ratio in data going back to fiscal Q4 2009.
- On a year-over-year basis, Asset Utilization Ratio has declined for 13 consecutive quarters, with an average decline of 8.2% over the last eight quarters.
- Peak year-over-year performance for Asset Utilization Ratio in the last five years was growth of 11.1% in fiscal Q3 2023, against a decline of 13.2% in fiscal Q3 2025 at the low end.
- Per Business Quant, the preceding three fiscal quarters came in at 0.60 (Q1 2027), 0.61 (Q4 2026) and 0.64 (Q3 2026).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Asset Util. (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,224.11 Bn | 1,197.72 Bn | 20.46 Bn | 0.60 |
| 2 | Johnson & Johnson | 665.34 Bn | 585.20 Bn | 17.30 Bn | 0.50 |
| 3 | AbbVie | 515.72 Bn | 483.73 Bn | 13.12 Bn | 0.47 |
| 4 | Merck | 362.64 Bn | 325.58 Bn | 13.19 Bn | 0.51 |
| 5 | Novartis Ag | 315.51 Bn | 288.75 Bn | - | - |
| 6 | Astrazeneca | 289.26 Bn | 263.15 Bn | 13.26 Bn | 0.50 |
| 7 | Amgen | 249.20 Bn | 200.85 Bn | 7.58 Bn | 0.41 |
| 8 | Gilead Sciences | 207.48 Bn | 182.59 Bn | 6.73 Bn | 0.62 |
| 9 | Pfizer | 167.49 Bn | 114.85 Bn | 12.56 Bn | 0.31 |
| 10 | Dr Reddys Laboratories | 12.40 Bn | 11.74 Bn | 472.93 Mn | 0.59 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | 0.59 |
| Jun 30, 2026 | 0.60 |
| Mar 31, 2026 | 0.61 |
| Dec 31, 2025 | 0.64 |
| Sep 30, 2025 | 0.65 |
| Jun 30, 2025 | 0.66 |
| Mar 31, 2025 | 0.68 |
| Dec 31, 2024 | 0.67 |
| Sep 30, 2024 | 0.68 |
| Jun 30, 2024 | 0.72 |
| Mar 31, 2024 | 0.74 |
| Dec 31, 2023 | 0.77 |
| Sep 30, 2023 | 0.78 |
| Jun 30, 2023 | 0.81 |
| Mar 31, 2023 | 0.83 |
| Dec 31, 2022 | 0.84 |
| Sep 30, 2022 | 0.83 |
| Jun 30, 2022 | 0.76 |
| Mar 31, 2022 | 0.76 |
| Dec 31, 2021 | 0.76 |
API Access
Dr Reddys Laboratories Asset Utilization Ratio API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=asset-utilization-ratio&ticker=RDY&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "asset-utilization-ratio", "ticker": "RDY", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=asset-utilization-ratio&ticker=RDY&period=max&api_key=YOUR_API_KEY");
const data = await res.json();